Ligand Pharmaceuticals reported $30.59M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Agenus AGEN:US $ 667K 438K
Amgen AMGN:US $ 1637M 147M
Anika Therapeutics ANIK:US $ 17.33M 4.01M
Baxter International BAX:US $ 1856M 75M
Bristol Myers Squibb BMY:US $ 2451M 52M
Clovis Oncology CLVS:US $ 9.64M 0.03M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Endo International Ordinary Shares ENDP:US $ 313.43M 23.44M
Flexion Therapeutics FLXN:US $ 4.98M 1.11M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
Glaxosmithkline GSK:US $ 2519M 108M
Harsco HSC:US $ 454.37M 33.29M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Insmed INSM:US $ 10.84M 993K
Intrexon XON:US $ 15.03M 2.06M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
Lannett LCI:US $ 83.35M 2.56M
Ligand Pharmaceuticals LGND:US $ 30.59M 22.44M
MacroGenics MGNX:US 22K 5K
Merk MRK:US $ 2684M 771M
Pacira Pharmaceuticals PCRX:US $ 35.25M 3.9M
Pfizer PFE:US $ 6992M 2820M
Rigel Pharmaceuticals RIGL:US $ 0.13M 0.19M
Teva Pharmaceutical Industries TEVA:US $ 1987M 76M
Veracyte VCYT:US $ 17.47M 5.07M